Pratima Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 30-12-2024
- Revenue -37.31%
(FY 2023)
- Profit -71.29%
(FY 2023)
- Ebitda -0.94%
(FY 2023)
- Net Worth 16.72%
(FY 2023)
- Total Assets 29.99%
(FY 2023)
About Pratima Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Pratima Singh and Deepak Singh serve as directors at the Company.
- CIN/LLPIN
U74999TG2018PTC122563
- Company No.
122563
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pratima Life Science Private Limited offer?
Pratima Life Science Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Aldehydes.
Who are the key members and board of directors at Pratima Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratima Singh  | Director | 27-Feb-2018 | Current |
| Deepak Singh | Director | 14-Jun-2021 | Current |
Financial Performance of Pratima Life Science.
Pratima Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.31% decrease. The company also saw a substantial fall in profitability, with a 71.29% decrease in profit. The company's net worth Soared by an impressive increase of 16.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pratima Life Science?
Unlock access to Pratima Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Dec 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Pratima Life Science?
Unlock and access historical data on people associated with Pratima Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pratima Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pratima Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
